Aromatase inhibitors are used in postmenopausal women with hormone-receptor-positive breast cancer | Medibuddy
27th February 2025

Aromatase inhibitors are used in postmenopausal women with hormone-receptor-positive breast cancer

Aromatase inhibitors are used in postmenopausal women with hormone-receptor-positive breast cancer. What is the most common reason for the discontinuation of aromatase inhibitor therapy?

Select the SINGLE most appropriate option from the list below. Select ONE option only.

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.